Merit E Cudkowicz Selected Research

Diphosphonates (Bisphosphonates)

1/2009

Profound muscle weakness and pain after one dose of actonel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Merit E Cudkowicz Research Topics

Disease

52	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2024 - 07/2003
12	Disease Progression 01/2023 - 05/2007
5	Atrophy 10/2021 - 03/2006
5	Huntington Disease (Huntington's Disease) 01/2017 - 03/2006
3	Neuroinflammatory Diseases 04/2024 - 05/2007
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 08/2003
3	Dizziness (Lightheadedness) 01/2019 - 09/2012
3	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 09/2018 - 01/2016
3	Parkinson Disease (Parkinson's Disease) 02/2014 - 06/2007
2	Fatigue 01/2019 - 09/2012
2	Muscle Cramp (Cramp) 03/2018 - 04/2016
2	Multiple Sclerosis 01/2018 - 01/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2015 - 05/2007
2	Nervous System Diseases (Neurological Disorders) 05/2013 - 11/2011
2	Motor Neuron Disease (Primary Lateral Sclerosis) 04/2009 - 05/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2008 - 06/2007
1	COVID-19 01/2023
1	Nephrolithiasis 01/2023
1	Infections 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Diarrhea 10/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Paresthesia (Dysesthesia) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 01/2022
1	Myasthenia Gravis 12/2021
1	Nausea 01/2019
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Chronic Progressive Multiple Sclerosis 01/2018
1	Headache (Headaches) 01/2018
1	Inflammation (Inflammations) 01/2015
1	Sarcoma (Soft Tissue Sarcoma) 04/2014
1	Urolithiasis 02/2014
1	Gout 02/2014
1	Neutropenia 11/2013
1	Cognitive Dysfunction 09/2012
1	Multiple System Atrophy 09/2012
1	Gliosis 04/2009

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 04/2024 - 12/2005
5	4-phenylbutyric acid (Buphenyl)FDA Link 01/2021 - 06/2005
4	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2015 - 01/2013
3	Uric Acid (Urate)IBA 01/2023 - 09/2012
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2007
3	Superoxide Dismutase-1IBA 01/2022 - 04/2014
3	Mexiletine (Mexitil)FDA LinkGeneric 01/2021 - 04/2016
3	ibudilastIBA 01/2021 - 01/2016
3	CK-2017357IBA 01/2019 - 09/2012
3	TroponinIBA 01/2019 - 09/2012
3	DexpramipexoleIBA 09/2014 - 01/2013
3	coenzyme Q10 (CoQ10)IBA 09/2010 - 03/2006
2	Inosine FDA Link 01/2023 - 02/2014
2	Nerve Growth Factors (Neurotrophins)IBA 01/2022 - 12/2019
2	Antisense OligonucleotidesIBA 01/2022 - 05/2013
2	ursodoxicoltaurineIBA 01/2021 - 01/2020
2	Retinaldehyde (Retinal)IBA 01/2018 - 01/2016
2	Glutamic Acid (Glutamate)FDA Link 01/2015 - 11/2014
1	reldesemtivIBA 01/2023
1	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023
1	lipid peroxidation inhibitorIBA 10/2022
1	RT001IBA 10/2022
1	tofersenIBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	GTP Phosphohydrolases (GTPases)IBA 01/2022
1	Dynamins (Dynamin)IBA 01/2022
1	JNK Mitogen-Activated Protein KinasesIBA 01/2022
1	Apolipoprotein B-100 (Apo B 100)IBA 01/2022
1	Cholinergic ReceptorsIBA 12/2021
1	Rituximab (Mabthera)FDA Link 12/2021
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 10/2021
1	ezogabine (retigabine)IBA 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Tamoxifen FDA LinkGeneric 01/2020
1	CreatineIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 11/2019
1	Neuroprotective AgentsIBA 11/2019
1	Indicators and Reagents (Reagents)IBA 07/2018
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018
1	Macrophage Migration-Inhibitory FactorsIBA 01/2018
1	Cyclic NucleotidesIBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	Cephalosporins (Cephalosporin Antibiotics)IBA 10/2014
1	CreatinineIBA 09/2014
1	Messenger RNA (mRNA)IBA 05/2013
1	Superoxide DismutaseIBA 11/2011
1	Immunoglobulin M (IgM)IBA 11/2011
1	AntigensIBA 11/2011
1	AntibodiesIBA 11/2011
1	Immunoglobulin G (IgG)IBA 11/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2011
1	Riluzole FDA LinkGeneric 04/2009

Therapy/Procedure

11	Therapeutics 01/2022 - 03/2006
2	Noninvasive Ventilation 01/2022 - 07/2011
1	Personal Protective Equipment 01/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Drug Tapering 01/2022
1	Blood Component Removal (Apheresis) 01/2022